Management of hepatitis C patients by primary care physicians in the USA: Results of a national survey

Journal of Viral Hepatitis

Volumn 8, Issue 5, 2001, Pages 377-383

  Shehab, T M ^a   Sonnad, S S ^b   Lok, A S F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Diagnosis; Epidemiology; Interferon; Risk factors; Survey; Treatment

Indexed keywords

AMINOTRANSFERASE; LIVER ENZYME;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; INFECTION RISK; MALE; PATIENT REFERRAL; PHYSICIAN; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; SCREENING; UNITED STATES;

ADULT; FEMALE; HEALTH CARE SURVEYS; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT EDUCATION; PATIENTS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; RISK FACTORS; UNITED STATES;

EID: 0035726250     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2001.00310.x     Document Type: Article

References (28)

1. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
2. National Institutes of Health consensus development conference panel statement: Management of hepatitis C
3. Recommendations for prevention, control of hepatitis C, virus (HCV) infection and HCV-related chronic disease
4. Hepatitis C
5. Current practice patterns of primary care physicians in the management of patients with hepatitis C
6. The challenge of defining and counting generalist physicians: An analysis of Physician Masterfile data
7. Self-reported physician specialties and the primary care content of medical practice: A study of the AMA physician masterfile
8. Differences between generalist and subspecialist physicians regarding Helicobacter pylori and peptic ulcer disease
9. Family physicians' attitudes about and use of clinical practice guidelines
10. Management of hepatitis C, a national survey of gastroenterologists and hepatologists
11. The effect of race and sex on physicians' recommendations for cardiac catheterization
12. Lying for patients: Physician deception of third-party payers
13. Understanding the decision to participate in a survey
14. Trends in nonresponse rates
15. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection
16. A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use
17. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish hepatology research group
18. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C
19. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C
20. Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basic trainee blood donors
21. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients
22. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines
23. Changing physician performance. A systematic review of the effect of continuing medical education strategies
24. Diagnosis of hepatitis C
25. Diagnostic tests for hepatitis C
26. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
27. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus